Clinical Trial Detail

NCT ID NCT01614197
Title A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Therapeutic Advances in Childhood Leukemia Consortium
Indications

non-Hodgkin lymphoma

acute lymphocytic leukemia

Therapies

Etoposide

Cyclophosphamide

Prednisone

Cytarabine

Temsirolimus

Methotrexate

Age Groups: child adult

No variant requirements are available.